Antihypertensive efficacy and orthostatic tolerance of bunazosin vs nitrendipine: A multicentre double-blind randomized controlled study

Journal of Human Hypertension

Volumn 10, Issue 12, 1996, Pages 831-836

  Langenfeld, M R W ^a   Brautigam M ^b   Weidinger, G ^b   Assmann I ^c   Kronig B ^d   Schmieder, R E ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Sandoz AG Nürnberg   (Germany)

^c Clinic of Internal Medicine   (Germany)

^d Ev Elisabeth Krankenhaus Trier gemgGmbH   (Germany)

Author keywords

Bunazosin; Essential hypertension; Nitrendipine; Orthostatic dysregulation; Treatment

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BUNAZOSIN; CALCIUM CHANNEL BLOCKING AGENT; NITRENDIPINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESSENTIAL HYPERTENSION; FLUSHING; HEADACHE; HEART PALPITATION; HUMAN; LEG EDEMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; ORTHOSTATIC HYPOTENSION; PROVOCATION TEST; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TACHYCARDIA; VERTIGO;

ADRENERGIC ALPHA-ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; HUMANS; HYPERTENSION; LOWER BODY NEGATIVE PRESSURE; NITRENDIPINE; QUINAZOLINES;

EID: 0030433448     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mroczek WJ, Fotiu S, Davidov ME, Finnerty FA Jr. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo. Curr Ther Res 1974; 16: 769-777.
2. Smyth P, Pringle S, Jackson G, Lorimer AR. 24-hour control of blood pressure by once daily doxazosin: a multicentre double-blind comparison with placebo. Eur J Clin Pharmacol 1988; 34: 613-618.
3. Khoury AF, Kaplan NM. α-blocker therapy of hypertension. JAMA 1991; 26: 394-398.
4. Grimm RH Jr. α1-antagonists in the treatment of hypertension. Hypertension 1989; 13 (Suppl I): 131-136.
5. Kirsten R, Weidinger G. Behandlung der essentiellen Hypertonie mit dem α1-Antagonisten Bunazosin retard. Eine multizentrisch-doppelblinde, Plazebokontrollierte Studie. Drug Res 1994; 44: 13-16.
6. The 1988 Joint National Committee. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988; 148: 1023-1038.
7. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Am. NIH Publication, Bethesda, Maryland No 93-1088, 1993; pp 11-30.
8. Recommendations of the German Hypertension Liga, Heidelberg, 1994.
9. Graham RM et al. Prazosin: the first-dose phenomenon. Br Med J 1976; 27: 1293-1294.
10. Sasaki J, Uzawa H, Arakawa K. Comparative effects of bunazosin and propranolol on serum lipids and apolipoproteins in patients with essential hypertension, Int J Clin Pharmacol 1989; 27: 402-407.
11. Yoshino G et al. The effect of Bunazosin, a new alpha 1-blocker, on plasma lipids in diabetic subjects with essential hypertension. Curr Ther Res 1989; 45: 677-683.
12. Suzuki M et al. Insulin sensitivity in nonobese, non-diabetic essential hypertension and its improvement by an α1-blocker (Bunazosin). Am J Hypertens 1992; 5: 869-874.
13. Schmieder RE et al. Impact of alpha-versus beta-blocker on hypertensive target organ damage. Am J Hypertens 1996 (in press).
14. Ventura H et al. Immediate hemodynamic effects of a new calcium channel blocking agent (nitrendipine) in essential hypertension. Am J Cardiol 1983; 51: 783-787.
15. Coca A et al. Comparative evaluation of the antihypertensive efficacy of once-daily amlodipine versus nitrendipine with 24-hour ambulatory blood pressure monitoring in essential hypertension. J Cardiovasc Pharmacol 1993; 22: 513-518.
16. Guazzi MD et al. Nitrendipine versus long-acting nifedipine in mild, moderate and severe hypertension. Angiology 1986; 37: 508-518.
17. Holzgraeve H et al. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Br Med J 1989; 299: 881-886.
18. Thulesius O. Die Diagnose der orthostatischen Hypotonie anhand einfacher Kreislaufparameter. In Dengler HJ (Ed.) 5. Rothenburger Gespräch, 25 und 26 Mai 1973, Schattauer Verlag, Stuttgart, New York, 1974, pp 177-186.
19. Schellong F, Lüderitz B. Regulationsprüfung des Kreislaufs. Darmstadt: Steinkopf, 1954.
20. Kirch W, Bräutigam M, Weidinger G. Bunazosin retard im Vergleich zu Hydrochlorothiazid. Antihypertensiver Effekt und Verträglichkeit. Münch med Wschr 1994; 130: 206-210.
21. Rieckert H, Weidinger G, Schardt FW. Orthostatic hypotension during antihypertensive treatment with bunazosin and prazosin. Drug Invest 1993; 5: 327-333.
22. Collins R et al. Blood pressure, stroke, and coronary heart disease. Lancet 1990; 335: 827-838.
23. Semple PF, Thorén P, Lever AF. Vasovagal reactions to cardiovascular drugs: the first-dose effect. J Hypertens 1988; 6: 601-606.
24. Lohmann FW et al. Antihypertensive Therapie mittels Blockade der α1-Rezeptoren. Klinischer Vergleich von Bunazosin und Doxazosin. Nieren- und Hochdruckkrankheiten 1994; 2: 63-69.